Elevat3 Capital
Overview
Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office, Apeiron Investment Group. It is a thesis-driven, stage-agnostic, long-term-oriented investment firm that focuses on industries undergoing radical change, including New Food, Psychedelics, Longevity, and Blockchain/AI. The firm prefers to lead or co-lead investment rounds in European high-growth tech companies.
Portfolio Companies
4
Website
elevat3.vcInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neodigital Versicherung AG | Nov 2020 | Series B | Lead |
| Formo | Sep 2024 | Series B | Lead |
| tiakis Biotech AG | Oct 2021 | Series A | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Elevat3 Capital based?
Elevat3 Capital is headquartered in Sliema, Sliema, Malta.
When was Elevat3 Capital founded?
Founding year information for Elevat3 Capital is not publicly available.
How many portfolio companies does Elevat3 Capital have?
Elevat3 Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Elevat3 Capital's portfolio?
Portfolio companies visible on Caplight include Neodigital Versicherung AG, Formo, tiakis Biotech AG.
What was Elevat3 Capital's most recent investment shown here?
Elevat3 Capital's most recent investment in this portfolio sample was in Formo in 2024.
What sectors does Elevat3 Capital focus on?
Elevat3 Capital focuses on Consumer & Commerce, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, FinTech, Consumer & Commerce.
What company stages does Elevat3 Capital focus on?
Elevat3 Capital typically invests at the Early stage.
What is Elevat3 Capital's AUM?
Elevat3 Capital's assets under management are estimated at over $250.0M.